|
mRNA-2808 Clinical Trials
1 actively recruiting trial across 1 location
Birmingham, Alabama1 trial
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
University of Alabama at Birmingham Hospital
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.